Expertise in
51
conditions

Marek A. Ruchala

Przybyszewskiego Street 49, 
Poznan, WP, PL 
Expertise in
51
conditions
Przybyszewskiego Street 49, 
Poznan, WP, PL 

Overview

Marek Ruchala practices practicing medicine in Poznan, Poland.

Mr. Ruchala is highly rated in 51 conditions, according to our data. His clinical expertise encompasses Hyperthyroidism, Graves Disease, Hypothyroidism, Thyroidectomy, and Hormone Replacement Therapy (HRT).

He is actively involved in clinical research, co-authoring 447 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Przybyszewskiego Street 49, Poznan, WP 60355, Poland

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 3, Prospective, Randomized, Double-blind, Multi-center Study of the Efficacy and Safety of Lanreotide Autogel®/Depot 120 mg Plus BSC vs. Placebo Plus BSC for Tumour Control in Subjects With Well Differentiated, Metastatic and/or Unresectable, Typical or Atypical, Lung Neuroendocrine Tumours
A Phase 3, Prospective, Randomized, Double-blind, Multi-center Study of the Efficacy and Safety of Lanreotide Autogel®/Depot 120 mg Plus BSC vs. Placebo Plus BSC for Tumour Control in Subjects With Well Differentiated, Metastatic and/or Unresectable, Typical or Atypical, Lung Neuroendocrine Tumours
Enrollment Status: Terminated
Publish Date: July 06, 2022
Intervention Type: Drug
Study Phase: Phase 3
An Open Label Study to Assess the Safety and Efficacy of COR-003 (Levoketoconazole) in the Treatment of Endogenous Cushing's Syndrome
An Open Label Study to Assess the Safety and Efficacy of COR-003 (Levoketoconazole) in the Treatment of Endogenous Cushing's Syndrome
Enrollment Status: Completed
Publish Date: April 19, 2021
Intervention Type: Drug
Study Phase: Phase 3
View 1 Less Clinical Trial

447 Total Publications

Salivary oxidative stress enzymes in patients with Graves orbitopathy: associations with clinical activity and treatment status.
Salivary oxidative stress enzymes in patients with Graves orbitopathy: associations with clinical activity and treatment status.
Journal: Polish archives of internal medicine
Published: July 07, 2026

Frequently Asked Questions about Marek A. Ruchala

Is Marek A. Ruchala a top-rated expert for Hyperthyroidism?

MediFind is an objective health platform that identifies experts based on real-world data. Marek A. Ruchala is classified as an Elite expert for Hyperthyroidism, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Marek A. Ruchala participate in research or clinical trials?

Yes. Marek A. Ruchala has published 447 articles and abstracts on conditions like Hyperthyroidism. You can view a list of Marek A. Ruchala's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Ruchala's expertise for a condition
ConditionClose
View All 13 Distinguished Conditions
View All 33 Advanced Conditions
View All 87 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile